Evolus Inc's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Income-Before-Tax" stands at -57.83 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
Evolus Inc's third quarter result of -15.57 Million USD for the item "Income Before Tax" represents an increase of 8.89 percent compared to it's second quarter result.
Also, Evolus Inc's third quarter result of -15.57 Million USD for the item "Income Before Tax" represents an increase of 18.21 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Evolus Inc's third quarter result of -57.83 Million USD for the item "Income Before Tax" represents an increase of 5.65 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -2.70 Million United States Dollars compared to the value the year prior.
The 1 year change is -2.70 Million United States Dollars.
The 3 year change is 21.55 Million United States Dollars.
The 5 year change is 8.90 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Income Before Tax | 905,699,262,464.00 |
![]() | Johnson & Johnson - Income Before Tax | 486,508,953,600.00 |
![]() | AbbVie Inc - Income Before Tax | 399,570,305,024.00 |
![]() | Roche Holding AG - Income Before Tax | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Income Before Tax | 280,205,508,085.11 |